Latest Breaking News On - Loss widens in q1 - Page 1 : comparemela.com

PDS Biotechnology Corp. (PDSB), a clinical-stage immunotherapy company, Monday, reported a wider loss for the first quarter, particularly impacted by personnel, clinical studies, medical affairs, and manufacturing expenses.

Thomson-reuters
Biotechnology-corp
Loss-widens-in-q1
Pds-biotechnology-corp
Linical-stage-immunotherapy-company